Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

2-OHOA With RT and TMZ for Adults With Glioblastoma (CLINGLIO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04250922
Recruitment Status : Recruiting
First Posted : January 31, 2020
Last Update Posted : July 19, 2021
Sponsor:
Collaborators:
Covance
Northern Institute for Cancer Research, Newcastle
Theradis pharma
LIPODOM THERAPEUTICS
Information provided by (Responsible Party):
Laminar Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 30, 2022
Estimated Study Completion Date : October 30, 2023